Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients

By Kangarloo Shahbal   Gangopadhyay Suman   Syme Rachel   Wolff Johannes   Glück Stefan  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 9-19

Humana Press, Inc

Access to resources Recommend Favorite

Cisplatin Pharmacokinetics in Children with Cancer

By Peng B.   English M.W.   Boddy A.V.   Price L.   Wyllie R.   Pearson A.D.J.   Tilby M.J.   Newell D.R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1823-1828

Elsevier

Access to resources Recommend Favorite

Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer

By Boucaud M.   Pinguet F.   Poujol S.   Romieu G.   Cupissol D.   Astre C.   Culine S.   Bressolle F.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2357-2364

Elsevier

Access to resources Recommend Favorite

Topotecan preceded by oxaliplatin using a 3 week schedule - a phase I study in advanced cancer patients

By Gross-Goupil M.   Lokiec F.   Lopez G.   Tigaud J.-M.   Hasbini A.   Romain D.   Misset J.-L.   Goldwasser F.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1888-1898

Elsevier

Access to resources Recommend Favorite

Phase 2 Evaluation of Topotecan Administered on a 3-Day Schedule in the Treatment of Platinum- and Paclitaxel-Refractory Ovarian Cancer

By Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 116-119

Elsevier

Access to resources Recommend Favorite